Ticker Scorecard - ALLK Basics Company: Allakos Inc. IPO Date: July 16, 2018 Sector: Healthcare Industry: Biotech Market Cap: $25.53M Activated in VL: True Average Daily Range Avg Daily Range: $1.16 | 3.37% Avg Daily Range (30 D): $0.04 | 5.25% Avg Daily Range (90 D): $0.05 | 5.78% Institutional Daily Volume Avg Daily Volume: .76M Avg Daily Volume (30 D): 3.57M Avg Daily Volume (90 D): 1.59M Trade Size Avg Trade Size (Sh.): 128 Avg Trade Size (Sh.) (30 D): 610 Avg Trade Size (Sh.) (90 D): 466 Institutional Trades Total Inst.Trades: 1,878 Avg Inst. Trade: $2.27M Avg Inst. Trade (30 D): $.72M Avg Inst. Trade (90 D): $1.1M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.73M Avg Closing Trade (30 D): $6.43M Avg Closing Trade (90 D): $6.43M Avg Closing Volume: 102.29K     News Feb 10, 2025 @ 10:36 PM Kuehn Law Encourages Investors of Allakos Inc. to ... Source: N/A Jan 31, 2025 @ 7:20 PM Deal Dispatch: Sage And Silvus Are Up For Sale, Mr... Source: Anthony Noto Nov 4, 2024 @ 6:00 PM Urticaria Clinical Trial Pipeline Accelerates: 20+... Source: Delveinsight Aug 7, 2024 @ 8:02 PM Allakos Provides Business Update and Reports Secon... Source: N/A Jun 25, 2024 @ 8:02 PM Allakos Announces Positive Results from its Ongoin... Source: Allakos Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-2.04 $-.21 $-.3 Diluted EPS $-2.04 $-.21 $-.3 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -178.75M $ -18.37M $ -26.68M Operating Income / Loss $ -186.44M $ -19.75M $ -28.63M Cost of Revenue $ $ $ Net Cash Flow $ -60.07M $ -16.05M $ -16.56M PE Ratio